Brentuximab Vedotin and Combination Chemotherapy in Treating Patients With CD30-Positive Peripheral T-cell Lymphoma
City of Hope Medical Center
City of Hope Medical Center
National Institutes of Health Clinical Center (CC)
City of Hope Medical Center
BeiGene
Northwestern University
City of Hope Medical Center
Seagen Inc.
University of Nebraska
Hoffmann-La Roche
Eastern Cooperative Oncology Group
Eastern Cooperative Oncology Group
Fred Hutchinson Cancer Center
National Cancer Institute (NCI)
Mayo Clinic
SWOG Cancer Research Network
Takeda
Masonic Cancer Center, University of Minnesota
National Cancer Institute (NCI)
Fred Hutchinson Cancer Center
Novartis
M.D. Anderson Cancer Center
Fred Hutchinson Cancer Center
Mayo Clinic
Roswell Park Cancer Institute
University of Chicago
Barbara Ann Karmanos Cancer Institute
Case Comprehensive Cancer Center
Wake Forest University Health Sciences
University of Arizona
Beth Israel Deaconess Medical Center
OHSU Knight Cancer Institute
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
University of Washington
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
National Institutes of Health Clinical Center (CC)
Alliance for Clinical Trials in Oncology
Seagen Inc.
Mayo Clinic
Seagen Inc.
National Cancer Institute (NCI)
National Cancer Institute (NCI)
SWOG Cancer Research Network
City of Hope Medical Center
Roswell Park Cancer Institute
National Cancer Institute (NCI)
National Cancer Institute (NCI)